Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
This modified growth hormone releasing hormone analog includes a Drug Affinity Complex that extends its half-life from minutes to 6-8 days
Richard Siegel, an endocrinologist and codirector of the Diabetes and Lipid Center at Tufts Medical Center
Ongoing biomarker monitoring supports early detection of adverse changes and informs dose adjustments or discontinuation decisions
However, cancer cells can circumvent this effect by rewiring their metabolism towards an oxidative phenotype, indicating that targeting LDH alone is insufficient (90, 220)
Unlike native -MSH, MT-2 is a superpotent, non-selective agonist across the melanocortin receptor subtypes, which has made it a widely used tool compound in melanocortin-system research
